
European Academy of Allergy and Clinical Immunology
EAACI on MedicMessClinical and Translational Allergy
In PubMed through PubMed Central. Fully open access. Published by Wiley for the European Academy of Allergy and Clinical Immunology.
Publishing in Clinical and Translational Allergy
Clinical and Translational Allergy is the open access journal of the European Academy of Allergy and Clinical Immunology. It covers educational, translational and clinical work in allergy and immunology. Authors can submit Original Articles, Review Articles, Letters, Hypotheses and Correspondence. Editorials require an invitation or prior editor consultation, while the society selects Position Paper authors. Animal studies must have direct clinical relevance.
There is no general fee-free publication route. The standard article charge is £2,930 before tax, with a society member discount, country waivers and possible institutional or funder coverage. The journal does not charge submission or page fees, and it excludes single case reports from Letters. Manuscripts receive single-blind peer review when the editor sends them to referees. Its 2025 median submission-to-first-decision time was 13 days, and its acceptance rate was 26%.
Free subscriber access
Free with a subscription: the author guide in one place
Word limits, abstract lengths and fees for each article type, and a checklist before you submit. Enter your email to unlock this journal and every other guide.
You'll also receive The Weekend Round every Saturday.- Editorial
Commissioned article discussion; unsolicited work needs editor approval, with no abstract or supplements and 100-word figure legends.
- Words
- 1,000
- Abstract
- —
- Figures & tables
- 2
- References
- 9
- Position Paper
EAACI Executive Committee selects the authors; more than 100 references need justification.
- Words
- 4,499
- Abstract
- 200
- Figures & tables
- 10
- References
- —
- Review Article
Updates recent developments in clinical allergy and immunology research.
- Words
- —
- Abstract
- 200
- Figures & tables
- 10
- References
- 200
- Original Article
Translational or clinical research; animal studies need clinical relevance, and extra display items need cover-letter reasons.
- Words
- —
- Abstract
- 250
- Figures & tables
- 6
- References
- —
- Letter
Brief original observations, not single cases; start 'To the Editor' and keep figure legends within 100 words.
- Words
- 900
- Abstract
- —
- Figures & tables
- 2
- References
- 9
- Hypothesis
New allergy or immunology hypotheses require editor agreement before peer review.
- Words
- 2,999
- Abstract
- —
- Figures & tables
- 5
- References
- 75
- Correspondence
Discussion of a published original article; cite it and allow its authors four weeks to respond.
- Words
- 599
- Abstract
- —
- Figures & tables
- 1
- References
- 6
The standard charge is £2,930 before applicable tax. EAACI members receive 10% off, and eligible countries receive automatic discounts or waivers. An institutional or funder agreement may cover the charge. There are no submission or page charges.
Before you submit
- Include a graphical abstract that summarises the main findings.
- Follow CONSORT for a clinical trial and consult STROBE for an epidemiological study.
- Include a data availability statement and cite any shared research data.
- Disclose AI-generated content in detail in the Methods section.
- Submit original image files and provide the submitting author's ORCID iD.
- Seek editor agreement before submitting a Hypothesis or an unsolicited Editorial.
Present it first.
Similar journals.
Frequently asked
- Is Clinical and Translational Allergy indexed in PubMed?
- Yes, through PubMed Central. Its articles are deposited in PMC and appear in PubMed with a PMID; it is not indexed in MEDLINE.
- How much does it cost to publish in Clinical and Translational Allergy?
- The article processing charge is £2,930.
- Does Clinical and Translational Allergy accept case reports?
- No. Clinical and Translational Allergy does not publish case reports.
- What is the Impact Factor of Clinical and Translational Allergy?
- Clinical and Translational Allergy states an Impact Factor of 4.2 for 2025.
- How long does Clinical and Translational Allergy take to decide?
- About 13 days from submission to first decision.
- What is the acceptance rate of Clinical and Translational Allergy?
- Clinical and Translational Allergy states that it accepts 26% of submissions.
- What kind of peer review does Clinical and Translational Allergy use?
- Single-blind peer review.
PubMed via PMC · APC £2,930 · First decision in 13 days
- Accepted work
- Original research · Literature review
- Acceptance rate
- 26%
- Peer review
- Single-blind
- Access
- Free to read
Checked against the journal’s author guide · updated 14 Oct 2026

